The GRADE Capillary Blood Collection Pilot Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02388100 |
Recruitment Status :
Completed
First Posted : March 13, 2015
Last Update Posted : December 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Type 2 Diabetes | Procedure: Capillary HbA1c collection |
Study Type : | Observational |
Actual Enrollment : | 70 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study) Capillary Blood Collection: A Pilot Study |
Study Start Date : | March 2015 |
Actual Primary Completion Date : | August 2016 |
Actual Study Completion Date : | August 2016 |

- HbA1c obtained from venous versus capillary measurements at one point in time for each participant. [ Time Frame: Cross sectional ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Current GRADE participant with a scheduled follow-up visit
Exclusion Criteria:
- GRADE participants attending first quarterly (Month 3) visit or an annual visit

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02388100
United States, Arizona | |
Southwestern American Indian Center | |
Phoenix, Arizona, United States | |
United States, Colorado | |
University of Colorado | |
Denver, Colorado, United States | |
United States, Hawaii | |
Pacific Health Research and Education Institute (VA Pacific Islands) | |
Honolulu, Hawaii, United States | |
United States, Louisiana | |
Pennington Biomedical Research Center | |
Baton Rouge, Louisiana, United States | |
United States, Minnesota | |
International Diabetes Center | |
Minneapolis, Minnesota, United States |
Study Chair: | David Nathan, MD | Massachusetts General Hospital |
Responsible Party: | GRADE Study Group |
ClinicalTrials.gov Identifier: | NCT02388100 |
Other Study ID Numbers: |
GRADE_CAP 1U01DK098246-01 ( U.S. NIH Grant/Contract ) |
First Posted: | March 13, 2015 Key Record Dates |
Last Update Posted: | December 20, 2016 |
Last Verified: | December 2016 |